BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 20, 2009
View Archived Issues
Provid and U.S. Department of Health & Human Services jointly divulge new Chk2 and RSK2 inhibitors
Read More
MRX-1024, an oral D-met suspension, protects against cisplatin-induced ototoxicity in humans
Read More
TRPV1-mediated analgesic activity is enhanced by repeated administration of ABT-102
Read More
Third quarter highlights at Takeda
Read More
CHMP issues positive opinion for Removab for malignant ascites
Read More
Nymox updates the FDA in regard to their phase III program for NX-1207
Read More
Arana discontinues PMX-53 development for ocular indications
Read More
Abbott and Enanta initiate phase I ABT-450 HCV protease inhibitor trial
Read More
Anacor presents results from phase II psoriasis trial with AN-2728
Read More
AVEO initiates phase Ib/IIa AV-951 trial in advanced breast cancer
Read More
AVI BioPharma treats first patient in AVI-4658 Duchenne muscular dystrophy trial
Read More
New gamma-secretase inhibitors reported in recent Schering-Plough patent
Read More
Seattle Genetics initiates pivotal SGN-35 trial for Hodgkin's lymphoma
Read More
Novel MMP-12 inhibitors imparted by AstraZeneca researchers
Read More
Obio presents update on company activities
Read More
Biosergen discloses novel antifungal agents
Read More
ECI concludes CTA with NIA for initiation of phase I clinical trial of ECI-301
Read More
sanofi-aventis imparts new cannabinoid CB2 receptor antagonists for pain relief
Read More
FDA accepts Nuvo's resubmission of MAA for Pennsaid in osteoarthritis
Read More
Conbriza receives positive CHMP opinion for osteoporosis
Read More
Eisai and Bial partner for European commercialization of Zebinix
Read More
CHMP recommends granting marketing authorization to Nycomed's Pantozol Control
Read More
Green tea extracts may neutralize the antitumor effects of bortezomib
Read More
Sucampo and Abbott sign Japanese license and commercialization agreement for Amitiza
Read More
Target of vitamin D in breast cancer cells identified
Read More
NSC-84093 inhibits melanophore migration in vitro
Read More